Your browser doesn't support javascript.
loading
Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose.
Krantz, Matthew S; Kwah, Jason H; Stone, Cosby A; Phillips, Elizabeth J; Ortega, Gilbert; Banerji, Aleena; Blumenthal, Kimberly G.
Afiliación
  • Krantz MS; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Kwah JH; Yale School of Medicine, Section of Rheumatology, Allergy, and Immunology, Department of Internal Medicine, New Haven, Connecticut.
  • Stone CA; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Phillips EJ; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Ortega G; Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Banerji A; Division of Allergy and Immunology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.
  • Blumenthal KG; Harvard Medical School, Boston, Massachusetts.
JAMA Intern Med ; 181(11): 1530-1533, 2021 11 01.
Article en En | MEDLINE | ID: mdl-34309623

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 Tipo de estudio: Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Intern Med Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 Tipo de estudio: Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Intern Med Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos